- Home
- Companies
- bioMérieux S.A.
- Services
- AKI Risk Assessment
AKI Risk Assessment
A Renal “Alarm System”: Acute kidney injury is increasingly prevalent,1 but unlike myocardial infarction, AKI often has no signs or symptoms, making risk assessment via traditional methods difficult.2 The NephroCheck Test, designed to help you evaluate critically ill patients’ risk of acute kidney injury, is a breakthrough in renal risk assessment.
The NephroCheck Test was created for use alongside clinical evaluation of critically ill patients over 21. With results in just 20 minutes, the test is intended to assist the clinician in assessing the risk of moderate to severe acute kidney injury in the next 12 hours.
Identify
Identify which patients may be at increased risk of developing AKI, and those who are at lower risk of developing AKI.
Stratify
Stratify patients who have a high (> 0.3) or the highest (> 2.0) risk of developing moderate to severe AKI in the next 12 hours.
Mitigate
The test results empower physicians to implement their preferred kidney-sparing strategies to potentially prevent permanent kidney damage or death.
Dr. Peter McCullough discusses how early identification is fundamental for treating acute kidney injury. The NephroCheck Test can help inform certain adjustments to critical care management.